Using another approach, by fusion of highly attenuated IL-21 mutein variant (R9E:R76A) to the C-terminus of the anti-PD-1 antibody, a bifunctional protein was obtained which provided protection in a human melanoma mouse model resistant to anti-PD-1 therapy. The gene discussed is IL21; the disease is melanoma.